Literature DB >> 34272570

[Surgical treatment and radiation therapy of brain metastases].

Jan P Boström1,2, Kathleen Jetschke3, Kirsten Schmieder3, Irenä Us A Adamietz4,5,6.   

Abstract

The aim of this work is to outline the principles of interdisciplinary treatment of brain metastases. Interdisciplinary treatment is determined by the clinical situation, anatomical conditions and tumor entity and has the goal of reducing toxicity. Magnetic resonance imaging, computed tomography (CT) and positron emission tomography-CT are used to diagnose brain metastases. Neurosurgery is used for accessible, symptomatic metastases. For localized metastases, including multiple metastases, that are surgically inaccessible, radiosurgery is used. If possible, partial brain irradiation is preferred to whole-brain irradiation. Protection of the hippocampus during whole-brain radiotherapy reduces therapy toxicity. In emergency situations, steroids provide effective support and a neurosurgical intervention may be life-saving. The options for systemic drug therapy are increasing.
© 2021. Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Combined modality therapy; Immunotherapy; Neurosurgery; Radiosurgery; Radiotherapy/stereotactic

Year:  2021        PMID: 34272570     DOI: 10.1007/s00117-021-00894-4

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  35 in total

Review 1.  New Strategies in Stereotactic Radiotherapy for Oligometastases.

Authors:  David A Palma; Alexander V Louie; George B Rodrigues
Journal:  Clin Cancer Res       Date:  2015-12-01       Impact factor: 12.531

Review 2.  Brain metastases.

Authors:  Achal Singh Achrol; Robert C Rennert; Carey Anders; Riccardo Soffietti; Manmeet S Ahluwalia; Lakshmi Nayak; Solange Peters; Nils D Arvold; Griffith R Harsh; Patricia S Steeg; Steven D Chang
Journal:  Nat Rev Dis Primers       Date:  2019-01-17       Impact factor: 52.329

3.  Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO).

Authors:  Riccardo Soffietti; Ufuk Abacioglu; Brigitta Baumert; Stephanie E Combs; Sara Kinhult; Johan M Kros; Christine Marosi; Philippe Metellus; Alexander Radbruch; Salvador S Villa Freixa; Michael Brada; Carmine M Carapella; Matthias Preusser; Emilie Le Rhun; Roberta Rudà; Joerg C Tonn; Damien C Weber; Michael Weller
Journal:  Neuro Oncol       Date:  2017-02-01       Impact factor: 12.300

Review 4.  Brain metastases.

Authors:  Jaime Gállego Pérez-Larraya; Jerzy Hildebrand
Journal:  Handb Clin Neurol       Date:  2014

5.  Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis.

Authors:  Naoki Niikura; Naoki Hayashi; Norikazu Masuda; Seiki Takashima; Rikiya Nakamura; Ken-ichi Watanabe; Chizuko Kanbayashi; Mayumi Ishida; Yasuo Hozumi; Michiko Tsuneizumi; Naoto Kondo; Yoichi Naito; Yayoi Honda; Akira Matsui; Tomomi Fujisawa; Risa Oshitanai; Hiroyuki Yasojima; Yutaka Tokuda; Shigehira Saji; Hiroji Iwata
Journal:  Breast Cancer Res Treat       Date:  2014-08-09       Impact factor: 4.872

Review 6.  The Interdisciplinary Management of Brain Metastases.

Authors:  Kirsten Schmieder; Ulrich Keilholz; Stephanie Combs
Journal:  Dtsch Arztebl Int       Date:  2016-06-17       Impact factor: 5.594

7.  Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study.

Authors:  Daniel N Cagney; Allison M Martin; Paul J Catalano; Amanda J Redig; Nancy U Lin; Eudocia Q Lee; Patrick Y Wen; Ian F Dunn; Wenya Linda Bi; Stephanie E Weiss; Daphne A Haas-Kogan; Brian M Alexander; Ayal A Aizer
Journal:  Neuro Oncol       Date:  2017-10-19       Impact factor: 12.300

8.  Clinical Benefits of Combining Different Visualization Modalities in Neurosurgery.

Authors:  Karl-Michael Schebesch; Katharina Rosengarth; Alexander Brawanski; Martin Proescholdt; Christina Wendl; Julius Höhne; Christian Ott; Hans Lamecker; Christian Doenitz
Journal:  Front Surg       Date:  2019-10-01

9.  Risks of postoperative paresis in motor eloquently and non-eloquently located brain metastases.

Authors:  Thomas Obermueller; Michael Schaeffner; Julia Gerhardt; Bernhard Meyer; Florian Ringel; Sandro M Krieg
Journal:  BMC Cancer       Date:  2014-01-14       Impact factor: 4.430

10.  Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial.

Authors:  Paula Mulvenna; Matthew Nankivell; Rachael Barton; Corinne Faivre-Finn; Paula Wilson; Elaine McColl; Barbara Moore; Iona Brisbane; David Ardron; Tanya Holt; Sally Morgan; Caroline Lee; Kathryn Waite; Neil Bayman; Cheryl Pugh; Benjamin Sydes; Richard Stephens; Mahesh K Parmar; Ruth E Langley
Journal:  Lancet       Date:  2016-09-04       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.